Ovarian cancer is a common and lethal cancer affecting women globally. Berbamine is a natural compound from the plant Berberis amurensis, which is used in Chinese traditional medicine. Recent studies have shown the anti-tumor effects of berbamine in several types of cancers but not in ovarian cancer. In the present study, we investigated the potential anti-tumor effects of berbamine in ovarian cancer and explored the underlying molecular mechanisms. Berbamine suppressed the cell viability of ovarian cancer cells in a concentration-dependent manner as revealed by methyl thiazolyl tetrazolium assay. Berbamine also suppressed the cell growth and invasion of ovarian cancer cells as measured by colony formation and cell invasion assays, respectively. Flow cytometry experiments showed that berbamine increased cell apoptotic rate and induced cell cycle arrest at G 0 /G 1 phase in ovarian cancer cells. Western blot analysis showed that berbamine increased the protein levels of cleaved caspase-3, cleaved caspase-9, Bax, and decreased the protein level of Bcl-2 in ovarian cancer cells. Quantitative real-time PCR and western blot analysis demonstrated that berbamine treatment inhibited the Wnt/β-catenin signaling in ovarian cancer cells. The inhibitory effects of berbamine on cell viability and invasion of ovarian cancer cells can be partially reversed by lithium chloride (LiCl) treatment. Growth of tumors developed from SKOV3 cells was significantly suppressed in berbaminetreated group, and berbamine treatment enhanced caspase-3 and -9 cleavage and reduced β-catenin protein level in tumor tissues. In summary, berbamine exerts its anti-cancer effects in vitro and in vivo via induction of apoptosis, partially associated with the inhibition of Wnt/β-catenin signaling.
Introduction
Ovarian cancer is a common and lethal cancer affecting women globally [1, 2] . Among the gynecologic malignances (cervical, ovarian, and uterine), ovarian cancer has the highest rate of death. In China, it shows an increasing trend in the incidence and mortality with an estimated 50,000 new cases and 22,000 deaths from this disease each year [3] . The high mortality is mainly attributed to the fact that most ovarian cancers are undiagnosed until advanced stages. The standard treatment in the initial chemotherapeutic management of advanced ovarian cancer is the combination of a platinum agent, including carboplatin or cisplatin and a taxane agent like paclitaxel or docetaxel, given intravenously [4] . Most ovarian cancer patients respond to initial chemotherapy, but the long-term survival remains poor, and they experience a relapse, with a median progression-free survival of only 16 months. The 5-year survival rate is only~46% [5] . Therefore, it is necessary to identify novel therapeutic approach for ovarian cancer treatment.
Berbamine ( Fig. 1 ), belonging to a bisbenzylisoquinoline alkaloid, is a natural compound from the plant Berberis amurensis which is used in Chinese traditional medicine [6] . Over the past decades, berbamine was used in China and Japan as an agent in treating leucopenia [7] . In addition, both animal and clinical studies showed that berbamine could stimulate normal hematopoiesis of cancer patients and reduce the cytotoxic effects of chemotherapeutic agents on bone marrow [8] . Early studies showed that berbamine induced apoptosis and growth inhibition of human leukemia HL-60 and K562 cell lines without cytotoxicity to normal hematopoietic cells [9] [10] [11] . It induced caspase-3-dependent apoptosis of leukemia cells via survivin-mediated pathway or suppressing the expression of Bcr/ Abl fusion gene [12] . Berbamine also led to loss of mitochondrial membrane potential and caused apoptosis and cell cycle arrest in human hepatoma cells [13] . However, whether berbamine has inhibitory activities against human ovarian cancer cells is unclear.
In this study, we investigated the effects of berbamine on cell viability, cell growth, and migration in human ovarian cancer cell lines SKOV3 and ES2, and explored its molecular mechanisms of action. Our results showed that berbamine inhibited cell proliferation, cell growth, and cell invasion of ovarian cancer cells, and induced cell apoptosis and alterations in cell cycle in the ovarian cancer cells. Berbamine may exert its anti-cancer activity through the induction of apoptosis signaling and suppression of the Wnt/β-catenin signaling.
Materials and Methods

Cell lines and culture
Human ovarian cancer cell lines SKOV3 and ES2 were purchased from ATCC (Manassas, USA). Cells were cultured in DMEM medium supplemented with 10% fetal bovine serum (FBS; Sigma, St Louis, USA) and antibiotics in a humidified atmosphere of 5% CO 2 at 37°C.
Cell viability assay
SKOV3 and ES2 cells were seeded into wells (5000 cells/well) of 96-well plates in 0.1 ml full DMEM medium. Twenty-four hours later, the fresh medium containing different concentrations (0-32 μg/ml) of berbamine (Sigma; 99% purity) was added and incubated for 24 h, 48 h or 72 h, or fresh medium containing berbamine (16 μg/ ml), LiCl (10 mM), or berbamine (16 μg/ml) + LiCl (10 mM) were added and incubated for 48 h. At the end of treatment, methyl thiazolyl tetrazolium (MTT) assay was used to measure cell viability. Cell survival rate was calculated as the percentage of MTT inhibition as follows: percentage of survival = (mean experimental absorbance/mean control absorbance) × 100%.
Colony formation assay
For colony formation assay, SKOV3 and ES2 cells were treated with berbamine (16 μg/ml) for 48 h, and were then seeded in triplicate in wells of 6-well plates at the density of 500 cells/well. After 14 days of growth, the cells were washed with PBS for three times followed by being fixed with 4% paraformaldehyde for 20 min. The cells were then stained with 0.1% crystal violet for 20 min, and were finally washed with PBS for three times. Images were captured and the numbers of the cell colonies in three independent samples were counted.
Invasion assay
For the invasion assays, SKOV3 and ES2 cells were treated with berbamine (16 μg/ml), LiCl (10 mM) or berbamine (16 μg/ml) + LiCl (10 mM) for 48 h, and then cells were seeded in the top chamber of a Matrigel-coated membrane insert (8-μm pore size; BD Biosciences, San Jose, USA) in a serum-free medium. The chemoattractant in the lower chamber was the medium supplemented with 10% FBS. After incubation for 48 h at 37°C and 5% CO 2 in a culture incubator, the non-invading cells were removed from the upper sides and the invaded cells on the lower sides of the inserts were stained with crystal violet and counted.
Annexin V/propidium iodide staining assay Apoptosis was assessed by using an Annexin V-FITC apoptosis detection kit (Thermo Fisher Scientific, Waltham, USA). After berbamine (16 μg/ml) treatment for 48 h, cells were collected, washed, and re-suspended in 500 μl of staining solution containing FITCconjugated Annexin V and propidium iodide (PI) and incubated on ice for 30 min according to the protocol. Then cells were analyzed by using BD FACSCalibur flow cytometer (BD BioSciences, San Jose, USA). The percentage of cells undergoing apoptosis was determined by three independent experiments. Table 1 . Sequences of primers used in qRT-PCR
Gene
Forward primer Reverse primer
Flow cytometric analysis of cell cycle status
The cell cycle status was evaluated by flow cytometry. In brief, 2 × 10 6 SKOV3 and ES2 cells were treated with berbamine (16 μg/ml) for 48 h, and then washed twice with PBS. The cells were fixed with 70% ethanol at 4°C overnight, and then stained with PI solution containing PI and RNase for 60 min. After flow cytometric analysis, the percentage of cells in the G 0 /G 1 , S and G 2 /M phase were calculated using CellQuest software (BD Biosciences).
Quantitative real-time PCR
After treatment with berbamine (16 μg/ml) for 48 h, cells were collected and total RNA was extracted in Trizol reagent (Takara, Dalian, China) according to the manufacture's protocol. Then 100 ng of total RNA sample was reverse-transcribed to cDNA using a commercial kit (Takara). qRT-PCR was then performed by using Power SYBR ® Green PCR Master Mix (Takara). The primers are shown in Table 1 . For the analysis of qTR-PCR data, the relative expression of target mRNA was determined by dividing the target amount by endogenous control amount to obtain a normalized target value. Then the normalized values of the target mRNA were compared among the samples.
Western blot analysis
After treatment with berbamine (16 μg/ml) for 48 h, cells were collected and whole cell lysates were prepared and quantified according to established methods [14] . The proteins in the cytoplasmic and nuclear fractions were prepared using the NE-PER extraction kit according to the manufacturer's instruction (Thermo Fisher Scientific). Western blot analysis was performed using antibodies against total caspase-3, total caspase-9, cleaved caspase-3, cleaved caspase-9, Bax, Bcl-2, β-catenin, GSK-3β, c-myc, cyclin D1, GAPDH, α-tubulin, and lamin A (Abcam, Cambridge, UK).
In vivo study using xenograft model
Male BABL/C nu/nu mice (20-23 g; 5-6 weeks old) were obtained from the Laboratory Animal Center of Shanghai Institutes for Biological Sciences (Shanghai, China). Mice were raised under specific pathogen-free conditions. Mice were allowed to acclimate for at least 1 week after arrival. All animal experiment procedures were approved by Ethics Committee of the Northwest Women and Children's Hospital.
SKOV3 cells were injected subcutaneously in the midline dorsal region of nude mice. At 24 h post injection, mice were randomly assigned to two groups (treated group and control group, six mice per group). Berbamine dissolved in isotonic saline at a concentration of 12 mg/ml was administered intravenously twice a day at a dosage of 60 mg/kg and an injection volume of 5 ml/kg for 4 weeks, and the dosage selection was based on previous studies [15] . The mice in the control group were given equal volumes of isotonic saline. Tumor volumes were measured with calipers every 7 days. At the end of the experiment, the mice were sacrificed by cervical dislocation, and dissected tumors were weighed and processed to further determine the expressions of proteins including β-catenin, cleaved caspase-3, cleaved caspase-9, total caspase-3, and total caspase-9 by western blot analysis.
Statistical analysis
All the data were shown as the mean ± standard deviation. Graphpad Prism Version 6.0 was used for statistical analysis. The t-test was used to examine the relationship between two groups. One-way ANOVA followed by post hoc Bonferroni test was used when multiple comparisons were made. A two-sided P < 0.05 was considered statistically significant.
Results
Berbamine inhibits the proliferation of SKOV3 and ES2 cells
Two ovarian cancer cell lines were selected to evaluate the inhibitory effect of berbamine on cell proliferation. Both concentrationdependent and time-dependent studies were performed. The results showed that berbamine treatment resulted in inhibition of the proliferation of SKOV3 cells at 24 h, 48 h, or 72 h in a concentrationdependent manner. The IC 50 values are 8.3 μg/ml, 5.7 μg/ml and 4.7 μg/ml at these three time points, respectively as shown in Fig. 2A . Similarly, in ES2 cells, the IC 50 values are 8.7 μg/ml, 7.0 μg/ ml and 5.3 μg/ml at 24 h, 48 h, or 72 h, respectively (Fig. 2B) . These results suggested that berbamine inhibits the proliferation of ovarian cancer cells in vitro. Since berbamine at 16 μg/ml was effective to reduce cell proliferation by~70%, and higher concentration (i.e. 32 μg/ml) may have non-specific pharmacological effects, 16 μg/ml berbamine was selected for the subsequent experiments.
Effect of berbamine on cell growth and invasion in ovarian cancer cells
To further evaluate the inhibitory effect of berbamine on the cell growth of ovarian cancer cells, we performed colony formation assay. Consistent with the results of the MTT proliferation assay, the colony-forming efficiencies were significantly reduced by berbamine treatment in both SKOV3 (Fig. 3A) and ES2 cells (Fig. 3B) .
Transwell assay was used to detect the effect of berbamine on cell invasion. Our results showed that the invasive capacity of SKOV3 cells exposed to berbamine was significantly decreased when compared with that of the control cells (Fig. 3C) . Similarly, berbamine also inhibited ES2 cell invasion in vitro (Fig. 3D) .
Berbamine induces apoptosis of ovarian cancer cells
To investigate whether berbamine-mediated growth inhibition is associated with apoptosis, simultaneous staining with Annexin V-FITC and PI was used, which distinguished between intact cells, apoptosis and cell death. Apoptosis analysis of cells exposed to berbamine showed that 50.8% ± 12.3% SKOV3 cells were undergoing apoptosis (Fig. 4A ) and 53.9% ± 12.3% ES2 cells were undergoing apoptosis (Fig. 4B ), which were significantly higher than those of the corresponding control cells.
Next, flow cytometric analysis was used to measure the percentage of different cell cycle phases after 48 h of treatment with 16 μg/ml berbamine. The results indicated that SKOV3 cells in G 0 /G 1 were markedly increased from 62.7% ± 11.2% to 74.1% ± 6.9%, while those in the G 2 /M phase were decreased from 18.8% ± 5.1% to 6.5% ± 3.0% (Fig. 4C) . ES2 cells showed the similar pattern. Cells in G 0 /G 1 were significantly increased from 56.7% ± 6.5% to 69.3% ± 9.2% and those in the G 2 /M phase were decreased from 22.4% ± 6.5% to 9.3% ± 3.7% (Fig. 4D) .
Effect of berbamine on apoptosis-related proteins
Since berbamine induces apoptosis of ovarian cancer cells, we next evaluated its effect on the expressions of some apoptosis-related proteins by western blot analysis. As expected, the pro-apoptotic proteins including cleaved caspase-3, cleaved caspase-9, and Bax were up-regulated, while the anti-apoptotic Bcl-2 was down-regulated after 48 h of treatment with 16 μg/ml berbamine in both SKOV3 and ES2 cells (Fig. 5A,B) .
Berbamine suppresses WNT/β-catenin pathway in ovarian cancer cells
To explore the potential mechanism of berbamine in ovarian cancer cells, the expressions of β-catenin and its target genes (GSK-3β, c-myc, and cyclin D1) in the Wnt/β-catenin pathway were detected by qRT-PCR and western blot analysis in SKOV3 cells after treatment with 16 μg/ml berbamine. Our data showed that berbamine suppressed the mRNA and protein expressions of β-catenin, c-myc and cyclin D1, and increased the mRNA and protein expressions of GSK-3β in SKOV3 cells (Fig. 6A,B) , suggesting that berbamine can repress the Wnt/β-catenin pathway in ovarian cancer cells. In addition, berbamine treatment also suppressed the protein expression levels of β-catenin in both cytosol and nucleus of SKOV3 cells (Fig. 6C,D) . In the in vitro functional assays (MTT and cell invasion assays), treatment with 10 mM LiCl, which activates the Wnt/β-catenin Figure 5 . Effects of berbamine on the protein levels of cell apoptosis-related factors in ovarian cancer cells (A,B) Protein levels of cleaved caspase-3, cleaved caspase-9, Bax, and Bcl-2 in SKOV3 (A) and ES2 (B) cells were determined by western blot analysis after treatment with berbamine (16 μg/ml) for 48 h. n = 3. *P < 0.05. signaling, was found to attenuate the inhibitory effects of berbamine on cell viability and cell invasion (Fig. 6E,F) .
Effect of berbamine on tumor growth in vivo
To examine the anti-tumor effect of berbamine, nude mice were treated with 60 mg/kg berbamine twice a day for up to 4 weeks. Nude mice in the control group were given equal volume of isotonic saline. Mice from both groups showed a gradual loss of body weight (Fig. 7A) . The tumor volume in the berbamine-treated mice was significantly smaller at Day 21, 28, and 35 after SKOV3 cell inoculation (Fig. 7B) . The tumor weight in the berbamine-treated mice was also significantly lower than that in control group (Fig. 7C) .
The protein levels of cleaved caspase-3 and β-catenin in tumor tissues were determined by western blot analysis, and the result showed that berbamine treatment increased the protein level of cleaved caspase-3 and decreased the protein level of β-catenin in the tumor tissues (Fig. 7D) . In addition, the protein level of cleaved caspase-9 in tumor tissues was also decreased in berbamine treatment group (Supplementary Fig. S1 ), while the protein levels of total caspase-3 and total caspase-9 in tumor tissues were not affected by berbamine (Supplementary Fig. S1 ).
Discussion
Ovarian cancer is still the leading cause of death in women suffering from gynecological cancer [16, 17] . It is often diagnosed at advanced stages (stage III or IV), making it a silent killer. The current standard of care for ovarian cancer involves surgery and platinum-based chemotherapy, but the overall cure rate is <40% [4] . The only exception is that the monoclonal antibody bevacizumab showed a moderate effect [18] . As a result, new therapies are urgently needed to improve the clinical outcome.
Herbal medicine is popular in China and other countries in Asia. Berbamine is the product derived from the plant B. amurensis and has Figure 6 . Effects of berbamine on Wnt/β-catenin signaling in ovarian cancer cells (A) The mRNA levels of β-catenin, GSK-3β, c-myc, and cyclin D1 in SKOV3 cells were determined by qRT-PCR assay after treatment with berbamine (16 μg/ml) for 48 h. (B) Protein levels of β-catenin, GSK-3β, c-myc, and cyclin D1 in SKOV3 cells were determined by western blot analysis after treatment with berbamine (16 μg/ml) for 48 h. Protein levels of β-catenin in the cytosol (C) and nucleus (D) of SKOV3 cells were determined by western blot analysis after treatment with berbamine (16 μg/ml) for 48 h. (E) Cell viability of SKOV3 cells was determined by MTT assay after treatment with berbamine (16 μg/ml), LiCl (10 mM), or berbamine (16 μg/ml) + LiCl (10 mM) for 48 h. (F) Cell invasion of SKOV3 cells was determined by cell invasion assay after treatment with berbamine (16 μg/ml), LiCl (10 mM), or berbamine (16 μg/ml) + LiCl (10 mM) for 48 h. n = 3. *P < 0.05. numerous bioactivities, namely anti-protozoa, anti-diarrheal, antimicrobial, and anti-trachoma [19] . The ameliorative effects of berbamine against different tumors have recently been reported, and the most promising results were from the studies of leukemia [7, [20] [21] [22] [23] . A clinical study has demonstrated that berbamine treatment markedly shortens the recovery time and prevents recurrence of neutropenia [7] . Viability and invasion activity of cultured ovarian cancer cells subjected to berbamine treatment were explored in this study. Our data showed that berbamine could greatly inhibit cancer cells proliferation in a concentration-dependent manner and suppress the invasion markedly. With regard to the possible mechanisms of anti-tumor effect of berbamine, induction of apoptosis was proposed, and the underlying mechanisms were also explored in the present study. Berbamine could induce apoptosis of ovarian cancer cells, increase the cells in G 0 /G 1 phase and decrease those in the G 2 /M phase. Moreover, berbamine could up-regulate the expressions of the pro-apoptotic proteins including cleaved caspase-3, cleaved caspase-9, and Bax, but down-regulate the anti-apoptotic protein Bcl-2.
Apoptosis is induced via two main routes, extrinsic pathway, and intrinsic pathway [24, 25] . The intrinsic pathway includes upregulating the ratio of Bax and Bcl-2, loss of mitochondrial transmembrane potential, release of cytochrome c from mitochondria and activating caspase-9 [26] . Bcl-2 and Bax are crucial regulators of cell apoptosis. Up-regulation of Bcl-2 can suppress cell apoptosis [27] . On the other hand, over-expressing Bax leads to apoptosis through cytosolic accumulation of cytochrome c released from mitochondria. In this study, berbamine was found to up-regulate Bax expression, down-regulate Bcl-2 expression, activate the downstream effector caspase-9 and the final effector caspase-3 [28] . This indicates that the intrinsic pathway of apoptosis is playing an important role in the process.
Activation of Wnt/β-catenin pathway has been shown to be associated with ovarian cancer initiation, metastasis, chemoresistance, and recurrence [29] . Berbamine was found to inhibit the growth of liver cancer cells and cancer initiating cells by targeting Ca 2+ /Calmodulindependent protein kinase II [14] and Ca 2+ /Calmodulin-dependent protein kinase II can directly impact the signal pathways including the Wnt/β-catenin [30, 31] , suggesting that berbamine may affect the Wnt/β-catenin signaling in cancer cells. However, the effect of berbamine treatment on the Wnt/β-catenin signaling has been not examined in the ovarian cancer. Our results showed that berbamine treatment significantly suppressed the Wnt/β-catenin signaling in the ovarian cancer cells, and the inhibitory effects of berbamine on cell viability and cell invasion of ovarian cancer cells could be partially reversed by LiCl treatment, Figure 7 . Effects of berbamine on tumor growth in vivo (A) Body weight of the nude mice was measured every 7 days for up to 35 days in both control group and berbamine group. (B) Tumor volume of the nude mice was measured every 7 days for up to 35 days in both control group and berbamine group. (C) Tumor weight in the nude mice was measured after the tumors were dissected. (D) Protein levels of cleaved caspase-3 and β-catenin were measured by western blot analysis in dissected tumors. n = 6. *P < 0.05, **P < 0.01.
suggesting that the inhibitory effects of berbamine on the ovarian cancer cell proliferation and migration may be partially via the inactivation of Wnt/β-catenin signaling. However, we only examined the Wnt/β-catenin signaling regarding berbamine-mediated anti-tumor effects in the present study. Other signaling pathways such as PI3K/Akt/mTOR or IKK/ IκB/NF-κB may also be involved in the berbamine-mediated effects in ovarian cancer cells, which requires further investigation. In the in vivo study, berbamine showed an inhibitory effect on the tumor growth. Previous studies also showed that berbamine treatment suppressed the in vivo tumor growth of lung cancer and chronic myeloid leukemia [15, 32] . Our study also showed that berbamine treatment increased the protein level of cleaved caspase-3 and decreased the protein level of β-catenin, suggesting that in vivo anti-tumor effects may involve the apoptosis pathway and Wnt/β-catenin signaling pathway.
In conclusion, our data indicate that berbamine exhibits a strong anti-cancer cell activity in ovarian cancer cells and the effects are possibly via the induction of apoptosis and inhibition of Wnt/β-catenin signaling. Berbamine may have the potential to be developed as a promising drug for the treatment of ovarian cancer.
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